Boost Biopharma, Inc
Boost Biopharma’s innovative Rapid Antigen Deployment (RAD) Process enables the rapid generation of protein subunit vaccine antigens and monoclonal antibodies. The company has developed vaccines for a wide range of pathogens of global importance, including SARS-CoV-2, Dengue virus, Zika virus, West Nile virus, and Japanese Encephalitis, with other vaccines and antibodies in development. Boost is collaborating with biopharmaceutical firms globally, including companies with existing approved and marketed vaccines. We offer single vaccine licenses, access to our inventory of antigens for commercial development, and prioritized access.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
4
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Boost Biopharma, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
Showing 1 of 3 verified contacts
Top roles at Boost Biopharma, Inc
2 distinct titles indexed · top 2 shown.
- 1chief scientific officer
- 1cofounder & chief executive officer
Sign up to unlock all 3 contacts at Boost Biopharma, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Boost Biopharma, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.